Stevan Lahr
Psychiatry · Tulsa, OKNPI 1740341577
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 289 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Johnson & Johnson at 32.6% of the total.
Across 289 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- Alkermes, Inc.$744
- Indivior Inc.$534
- Otsuka America Pharmaceutical, Inc.$485
- Neurocrine Biosciences, Inc.$261
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$214
- plus $978 from 11 others
What the payments were for
- Food & beverage$4,762100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 107 | $1,552 |
| Alkermes, Inc. | 44 | $744 |
| Indivior Inc. | 33 | $534 |
| Otsuka America Pharmaceutical, Inc. | 28 | $485 |
| Neurocrine Biosciences, Inc. | 11 | $261 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $214 |
| Vanda Pharmaceuticals Inc. | 6 | $162 |
| E.r. Squibb & Sons, L.L.C. | 10 | $154 |
| AbbVie(2 entities) | 6 | $126 |
| Axsome Therapeutics, Inc. | 5 | $111 |
| Sunovion Pharmaceuticals Inc. | 11 | $87 |
| Teva Pharmaceuticals USA, Inc. | 4 | $84 |
| Lundbeck LLC | 4 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $60 |
| Braeburn Inc. | 2 | $57 |
| Noven Therapeutics, LLC | 2 | $36 |
| Corium, LLC | 1 | $34 |
How this compares
$4,767 in reported general payments places this provider in the 85th percentile of 328 psychiatry providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 119 | $349,879 |
| Abilify MaintenaAripiprazole | 93 | $220,994 |
| Invega TrinzaPaliperidone Palmitate | 26 | $195,210 |
| AristadaAripiprazole Lauroxil | 23 | $67,151 |
| VraylarCariprazine Hcl | 34 | $47,157 |
| RexultiBrexpiprazole | 14 | $17,802 |
| Trazodone Hcl | 252 | $5,201 |
| Mirtazapine | 267 | $4,994 |
| Quetiapine Fumarate | 226 | $4,658 |
| VyvanseLisdexamfetamine Dimesylate | 11 | $4,263 |
| Ziprasidone Hcl | 83 | $4,221 |
| Buspirone Hcl | 227 | $4,051 |
| Hydroxyzine Hcl | 172 | $3,679 |
| Paliperidone ErPaliperidone | 36 | $3,613 |
| Haloperidol Decanoate | 60 | $3,611 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza | $1,552 | $545,089145 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $485 | $238,796107 claims |
| Alkermes, Inc.Aristada | $744 | $67,15123 claims |
| AbbVieVraylar | $126 | $47,15734 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $60 | $4,26311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 328 psychiatry providers in Oklahoma.
Other psychiatry in Tulsa
- Sarah LandTulsa$287K
- Bradley McClureTulsa$15K
- Katrina CraderTulsa$15K
- Jeffrey CatesTulsa$11K
- Kaitlin CoresTulsa$10K
- Charles van TuylTulsa$9K
- Michael DubriwnyTulsa$8K
- Martin PaulusTulsa$7K
- Joe SpeerTulsa$7K
- Kari YoumanTulsa$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.